These are offered to Radiotherapy clinics for simulating radiation therapy for each patient ahead of actual treatment in a totally risk-free environment, thus maximizing cancer patient safety and treatment effectiveness.

This solution is also sold to RT equipment manufacturers for machine-testing purposes. The company already generates revenues and has signed a commercial agreement with a leading radiation therapy company, Elekta A.B. As a winner of an R&D 100 Award, RTsafe’s PseudoPatient® has been recognized as one of the 100 most significant high-tech products worldwide for 2019.